Company intelligence / Profile preview

ProtaGene

Heilbronn, Baden-Württemberg, Germanyprotagene.com ↗

Ownership: Private
Development stage: Commercial

Overview

ProtaGene does not have its own clinical results or drug pipeline. It provides advanced analytical solutions to support the development and regulatory approval of biologics and cell/gene therapies for its clients. The company has supported over 400 biologic developments and participated in more than 50 gene and immune gene therapy clinical trials

Modalities: BiologicGene therapyCell therapyProteinDNA/RNA-based therapies
Industry: Contract Research Organization

Beyond the preview

Go deeper on ProtaGene.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ProtaGene.

Explore the full profile